Cleared Traditional

K140367 - ARCHITECT PX EXTRACELLULAR COLLAGEN MATRIX (FDA 510(k) Clearance)

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Sep 2014
Decision
210d
Days
-
Risk

K140367 is an FDA 510(k) clearance for the ARCHITECT PX EXTRACELLULAR COLLAGEN MATRIX. Classified as Wound Dressing With Animal-derived Material(s) (product code KGN).

Submitted by Harbor Medtech, Inc. (Irvine, US). The FDA issued a Cleared decision on September 12, 2014 after a review of 210 days - an extended review cycle.

This device falls under the General & Plastic Surgery FDA review panel. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the General & Plastic Surgery review framework, consistent with the majority of Class II 510(k) submissions.

View all Harbor Medtech, Inc. devices

Submission Details

510(k) Number K140367 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received February 14, 2014
Decision Date September 12, 2014
Days to Decision 210 days
Submission Type Traditional
Review Panel General & Plastic Surgery (SU)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
96d slower than avg
Panel avg: 114d · This submission: 210d
Pathway characteristics
Predicate-based equivalence.

Device Classification

Product Code KGN Wound Dressing With Animal-derived Material(s)
Device Class -

Regulatory Peers - KGN Wound Dressing With Animal-derived Material(s)

All 183
Devices cleared under the same product code (KGN) and FDA review panel - the closest regulatory comparables to K140367.
MatriDerm
K261224 · Medskin Solutions Dr. Suwelack AG · May 2026
Derma-Gide
K260532 · Geistlich Pharma AG · Mar 2026
LacertaMatrix
K260218 · Lacerta Life Sciences · Feb 2026
CollOvine™ Wound Powder
K253140 · Ovigenex, LLC · Feb 2026
Device 104 Particulate
K251323 · Geistlich Pharma AG · Jan 2026
LacertaMatrix
K252673 · Lacerta Life Science · Dec 2025